These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26358647)

  • 1. Pregnancy-induced changes in the pharmacokinetics of caffeine and its metabolites.
    Yu T; Campbell SC; Stockmann C; Tak C; Schoen K; Clark EA; Varner MW; Spigarelli MG; Sherwin CM
    J Clin Pharmacol; 2016 May; 56(5):590-6. PubMed ID: 26358647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of caffeine and its demethylated metabolites in lactating adult rabbits and neonatal offspring. Predictions of breast milk to serum concentration ratios.
    McNamara PJ; Burgio D; Yoo SD
    Drug Metab Dispos; 1992; 20(2):302-8. PubMed ID: 1352225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of theophylline, theobromine and paraxanthine in the fetal rat brain following a single oral dose of caffeine.
    Wilkinson JM; Pollard I
    Brain Res Dev Brain Res; 1993 Oct; 75(2):193-9. PubMed ID: 8261611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of caffeine and three metabolites in clinically normal horses and donkeys.
    Peck K; Mealey KL; Matthews NS; Taylor TS
    Am J Vet Res; 1997 Aug; 58(8):881-4. PubMed ID: 9256975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-Trimester Maternal Serum Paraxanthine, CYP1A2 Activity, and the Risk of Severe Preeclampsia.
    Eichelberger KY; Baker AM; Woodham PC; Haeri S; Strauss RA; Stuebe AM
    Obstet Gynecol; 2015 Oct; 126(4):725-730. PubMed ID: 26348183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraxanthine/Caffeine Concentration Ratios in Hair: An Alternative for Plasma-Based Phenotyping of Cytochrome P450 1A2?
    De Kesel PM; Lambert WE; Stove CP
    Clin Pharmacokinet; 2015 Jul; 54(7):771-81. PubMed ID: 25603821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics, metabolism and urinary detection time of caffeine in camels.
    Wasfi IA; Boni NS; Elghazali M; Abdel Hadi AA; Almuhrami AM; Barezaig IM; Alkatheeri NA
    Res Vet Sci; 2000 Aug; 69(1):69-74. PubMed ID: 10924397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1.
    Gu L; Gonzalez FJ; Kalow W; Tang BK
    Pharmacogenetics; 1992 Apr; 2(2):73-7. PubMed ID: 1302044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rutaecarpine on the metabolism and urinary excretion of caffeine in rats.
    Noh K; Seo YM; Lee SK; Bista SR; Kang MJ; Jahng Y; Kim E; Kang W; Jeong TC
    Arch Pharm Res; 2011 Jan; 34(1):119-25. PubMed ID: 21468923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The paraxanthine:caffeine ratio in serum or in saliva as a measure of CYP1A2 activity: when should the sample be obtained?
    Spigset O; Hägg S; Söderström E; Dahlqvist R
    Pharmacogenetics; 1999 Jun; 9(3):409-12. PubMed ID: 10471076
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum metabolite/caffeine ratios as a test for liver function.
    Jodynis-Liebert J; Flieger J; Matuszewska A; Juszczyk J
    J Clin Pharmacol; 2004 Apr; 44(4):338-47. PubMed ID: 15051740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of acute falciparum malaria on the disposition of caffeine and the comparison of saliva and plasma-derived pharmacokinetic parameters in adult Nigerians.
    Akinyinka OO; Sowunmi A; Honeywell R; Renwick AG
    Eur J Clin Pharmacol; 2000 May; 56(2):159-65. PubMed ID: 10877011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of CYP1A2 activity: a focus on caffeine as a probe.
    Perera V; Gross AS; McLachlan AJ
    Curr Drug Metab; 2012 Jun; 13(5):667-78. PubMed ID: 22554278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics.
    Perera V; Gross AS; Xu H; McLachlan AJ
    J Pharm Pharmacol; 2011 Sep; 63(9):1161-8. PubMed ID: 21827488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of pharmacokinetic interaction of aphobazole with CYP1A2 drug-substrate in experiments].
    Novitskaia IaG; Litvin AA; Viglinskaia AO; Zherdev VP
    Eksp Klin Farmakol; 2013; 76(6):30-3. PubMed ID: 24003488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of maternal pharmacokinetics using physiologically based pharmacokinetic models: assessing the impact of the longitudinal changes in the activity of CYP1A2, CYP2D6 and CYP3A4 enzymes during pregnancy.
    Abduljalil K; Pansari A; Jamei M
    J Pharmacokinet Pharmacodyn; 2020 Aug; 47(4):361-383. PubMed ID: 32840724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two novel methods for the determination of CYP1A2 activity using the paraxanthine/caffeine ratio.
    Doude van Troostwijk LJ; Koopmans RP; Guchelaar HJ
    Fundam Clin Pharmacol; 2003 Jun; 17(3):355-62. PubMed ID: 12803575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine and paraxanthine HPLC assay for CYP1A2 phenotype assessment using saliva and plasma.
    Perera V; Gross AS; McLachlan AJ
    Biomed Chromatogr; 2010 Oct; 24(10):1136-44. PubMed ID: 20853468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior.
    Cornelis MC; Kacprowski T; Menni C; Gustafsson S; Pivin E; Adamski J; Artati A; Eap CB; Ehret G; Friedrich N; Ganna A; Guessous I; Homuth G; Lind L; Magnusson PK; Mangino M; Pedersen NL; Pietzner M; Suhre K; Völzke H; ; Bochud M; Spector TD; Grabe HJ; Ingelsson E
    Hum Mol Genet; 2016 Dec; 25(24):5472-5482. PubMed ID: 27702941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man.
    Lelo A; Birkett DJ; Robson RA; Miners JO
    Br J Clin Pharmacol; 1986 Aug; 22(2):177-82. PubMed ID: 3756065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.